Shares of Cresco Labs Inc. (OTCMKTS:CRLBF – Get Free Report) have been given a consensus rating of “Buy” by the four research firms that are presently covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and two have assigned a strong buy recommendation to the company.
Separately, Canaccord Genuity Group downgraded shares of Cresco Labs from a “strong-buy” rating to a “moderate buy” rating in a research report on Tuesday, June 3rd.
Check Out Our Latest Stock Report on CRLBF
Cresco Labs Trading Up 6.8%
Cresco Labs (OTCMKTS:CRLBF – Get Free Report) last posted its quarterly earnings results on Friday, May 30th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.01). The firm had revenue of $165.76 million for the quarter, compared to analyst estimates of $164.37 million. Cresco Labs had a negative net margin of 11.86% and a negative return on equity of 21.77%. On average, analysts predict that Cresco Labs will post -0.2 EPS for the current year.
About Cresco Labs
Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
See Also
- Five stocks we like better than Cresco Labs
- How Investors Can Find the Best Cheap Dividend Stocks
- Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- How Marvell Went From Short Target to Breakout Star
- What is Short Interest? How to Use It
- Palo Alto Networks: The All‑in‑One Cybersecurity Powerhouse
Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.